The board of directors of Fine Foods & Pharmaceuticals NTM Spa on Monday approved its interim report as of March 31, which closed with a profit of EUR2.9 million compared to a loss of EUR2.5. | May 15, 2023
Fine Foods & Pharmaceuticals NTM Spa announced Monday that director Marco Costaguta has purchased 5,000 ordinary shares in the company. The shares were taken over at an average unit price of. | April 3, 2023
Fine Foods & Pharmaceuticals NTM on Thursday approved fiscal year 2022 results reporting a loss of EUR9.5 million worsening from a loss of EUR1.4 million in 2021. The board also approved a. | March 30, 2023